Evidence map›Paper›PMID 41294900›Full record

ArticleDiseases (Basel, Switzerland)2025

MicroRNA Signatures in Serous Ovarian Cancer: A Comparison of Prognostic Marker Targets in African Americans and Caucasians.

Jane M Muinde, Celina Romi Yamauchi, Joseph Cruz, Alena A McQuarter, Kyah Miller, Umang Sharma, Skyler Schiff, Isaac Kremsky, Saied Mirshahidi, Cody S Carter and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diseases (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jane M MuindeCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.ORCID 0000-0003-4501-3713
Celina Romi YamauchiCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.
Joseph CruzCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.
Alena A McQuarterCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.
Kyah MillerCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.
Umang SharmaSchool of Public Health, Loma Linda University, Loma Linda, CA 92350, USA.
Skyler SchiffCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.
Isaac KremskyBasic Science Research, School of Medicine, Loma Linda University, Loma Linda, CA 92350, USA.
Saied MirshahidiCancer Center, Biospecimen Laboratory, Loma Linda University, Loma Linda, CA 92350, USA.ORCID 0000-0003-1747-8070
Cody S CarterDepartment of Pathology and Human Anatomy, Loma Linda University, Loma Linda, CA 92350, USA.ORCID 0000-0002-7223-0900
Salma KhanCenter for Health Disparities, Loma Linda University, Loma Linda, CA 92350, USA.ORCID 0000-0003-2564-4358

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

health disparitiesmicroRNAsprognostic biomarkersserous ovarian cancer

Identifiers

PMID41294900
PMCPMC12650892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.